Freedom Capital Markets maintains Buy rating on Astrana Health, $50 price targetTradingView·Oct 1, 2026 at 12:17 PMASTH+2.78%
Astrana Health Showcases AI-Driven Value-Based Care StrategyTip Ranks·Sep 23, 2026 at 12:28 PMASTH+2.78%
Astrana Health flags material cybersecurity incident after social engineering attack on subsidiaryPUBT·Sep 23, 2026 at 11:31 AMASTH+2.78%
Astrana Health (ASTH) Could Be 32% Undervalued Following Its Recent PullbackSimplywall·Sep 18, 2026 at 06:02 PMASTH+2.78%
Searching for Overlooked Opportunities? Oppenheimer Top Analysts Point to These 2 'Strong Buy' StocksTip Ranks·Sep 18, 2026 at 09:59 AMASTH+2.78%
Astrana Health (NASDAQ:ASTH) Shares Up 7.9% - Still a Buy?Market Beat·Aug 14, 2026 at 07:00 PMASTH+2.78%DB-0.46%
Astrana Health ajukan Form 3; SVP Akuntansi John Vong laporkan kepemilikan 22.426 sahamPUBT·Aug 11, 2026 at 09:37 PMASTH+2.78%
ASTH: Q2 revenue up 49% YoY, EBITDA up 43%, guidance raised amid strong cash flow and risk managementQuartr·Aug 6, 2026 at 11:42 PMASTH+2.78%
Astrana Health Q2 2026 earnings: Revenue rises 49% as diluted EPS more than doublesTradingKey·Aug 6, 2026 at 08:26 PMASTH+2.78%
